Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-26-104120
Filing Date
2026-03-12
Accepted
2026-03-12 16:08:38
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 d907433ds3.htm S-3 272079
2 EX-5.1 d907433dex51.htm EX-5.1 19580
3 EX-23.1 d907433dex231.htm EX-23.1 1789
4 EX-FILING FEES d907433dexfilingfees.htm   iXBRL EX-FILING FEES 42122
5 GRAPHIC g907433dsp032.jpg GRAPHIC 6443
6 GRAPHIC g907433dsp033.jpg GRAPHIC 2921
7 GRAPHIC g907433g14j85.jpg GRAPHIC 61846
  Complete submission text file 0001193125-26-104120.txt   599389

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT d907433dexfilingfees_htm.xml XML 19602
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-294241 | Film No.: 26747729
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)